Fierce Pharma

MARCH 22, 2024

Sales are booming for Novo Nordisk’s GLP-1 treatments for diabetes and obesity. But that doesn’t mean the Danish company has moved on from its previous generation of blood sugar modulators. | With a positive recommendation from Europe’s Committee for Medicinal Products for Human Use (CHMP), Novo has come a step closer to bringing its revolutionary Awiqli (once weekly basal insulin icodec) to the market.

Medicine 308

Medicine Sales Marketing 308

MedCity News

MARCH 22, 2024

Today, new digital solutions are emerging that provide tailored exercise programs and encourage small changes to daily life that can lead to significantly lower fall risk.

Leads 112

Leads 112

Fierce Pharma

MARCH 22, 2024

At a watershed moment for Duchenne muscular dystrophy (DMD) treatment, privately held Italian drugmaker Italfarmaco has added a new therapeutic option to the armamentarium against the debilitating | At a watershed moment for Duchenne muscular dystrophy treatment, privately held Italian drugmaker Italfarmaco has added a new therapeutic option to the armamentarium against the debilitating muscle-wasting disorder.

FDA 234

FDA 234

MedCity News

MARCH 22, 2024

A CPO in the C-suite determines how a health system can move from a cost center to a revenue center with healthy operating margins by investing in specialty pharmacy services that reduce burden for healthcare staff and improve care for patients.

Healthcare 109

Healthcare Healthcare Patients 109

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MARCH 22, 2024

At a time of heightened geopolitical tensions between the U.S. and China, Eli Lilly’s CEO said the Indianapolis-based company remains committed to the Chinese market. | David Ricks’ visit to China comes as Lilly has several key drug applications under review at local regulators.

Marketing 220

Marketing 220

PM360

MARCH 22, 2024

AI-driven healthcare is making its way into our lives and with it comes positive changes Imagine a world where my AI emails your AI and they join forces to schedule our coffee chat. Next thing you know, we’re discussing campaign strategies over lattes, courtesy of our digital matchmakers. Welcome to the future, where AI in healthcare marketing isn’t just a concept— it’s the new normal.

Healthcare 104

Healthcare Healthcare Marketing Patients 104

MedCity News

MARCH 22, 2024

During a panel at HIMSS, three health system leaders explained what digital transformation means to them and how they’re seeking it play out at their organizations.

Medical 108

Medical Healthcare Healthcare 108

PM360

MARCH 22, 2024

It is with immense sadness that I write this. A one of a kind, loyal, and generous friend and mentor. I will miss his humor, unrivaled intelligence, guidance, wisdom—and I can’t leave out his fashion sense, especially those killer shoes. Rest in peace my very dear friend.

98

98

MedCity News

MARCH 22, 2024

Corticosteroids are a standard first-line treatment for Duchenne muscular dystrophy, but these drugs have many side effects. FDA approval of Italfarmaco’s Duvyzat is the first nonsteroidal drug to pass the agency’s regulatory bar for treating this rare disease.

Side effects 106

Side effects FDA Patients Biopharma 106

European Pharmaceutical Review

MARCH 22, 2024

Research suggests that combining ribociclib with hormone therapy improved invasive-free survival in stage 2 or 3 HR-positive, HER2-negative early breast cancer. The study data showed that distant disease-free survival and recurrence-free survival improved when the small molecule CDK4/6 inhibitor ribociclib was used alongside a nonsteroidal aromatase inhibitor (NSAI).

Medicine 97

Medicine Patients Pharmaceutical 97

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

MARCH 22, 2024

Medicare has loosened restrictions on the reimbursement of obesity drugs, thanks to clinical data showing they can improve cardiovascular outcomes, but their price could be up for negotiation.

105

105

Pharmaceutical Technology

MARCH 22, 2024

The EMA CHMP has recommended marketing authorisation for Novo Nordisk's Awiqli for treating diabetes in adult patients.

Marketing 105

Marketing Patients 105

pharmaphorum

MARCH 22, 2024

First report from PHTI concludes that digital health technologies for diabetes management deliver minimal clinical benefit and raise healthcare costs

Healthcare 116

Healthcare Healthcare Management 116

MedCity News

MARCH 22, 2024

Collaboration across key stakeholders, including home health agencies, providers, patients, health plans, and post-acute care solution providers will be critical to fully enabling the home as a preferred place of care.

Patients 91

Patients Healthcare Healthcare 91

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

MARCH 22, 2024

Italfarmaco’s non-steroidal drug Duvyzat (givinostat) has been approved in the US as a treatment for Duchenne muscular dystrophy (DMD)

FDA 111

FDA 111

Pharmaceutical Technology

MARCH 22, 2024

The US FDA has granted ODD to HI-Bio's felzartamab to treat antibody-mediated rejection (AMR) in kidney transplant recipients.

FDA 97

FDA 97

MedCity News

MARCH 22, 2024

Humana and DUOS have partnered to launch a new program that supports Humana’s Louisiana veteran seniors with a chronic condition. These veterans will be connected to DUOS, which can address their health-related social needs.

87

87

pharmaphorum

MARCH 22, 2024

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

FDA 104

FDA Pharmaceutical 104

Advertisement

PharmaTimes

MARCH 22, 2024

Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year

97

97

pharmaphorum

MARCH 22, 2024

It has been a bumper week for biotech financings, with a $400m Series A for Mirador heading, topping impressive rounds for Capstan, Clasp, Engrail, Enliven, and Nouscom.

104

104

PharmaTimes

MARCH 22, 2024

These types of conditions are responsible for 25% of all UK deaths and affect 7.

96

96

PharmaVoice

MARCH 22, 2024

After getting her start as a nurse, Debra Weiss worked her way up the corporate ladder and is now COO of Gates MRI, which just launched its first phase 3 trial for tuberculosis.

Leads 52

Leads Pharma 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Clarify Health

MARCH 22, 2024

While healthcare price transparency regulations aim to empower patients and promote competition in the market, providers face significant challenges in implementing and complying with these requirements effectively. Implementing price transparency requires a robust technology infrastructure to collect, store, update, and disseminate pricing information effectively.

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Competition 52

PM360

MARCH 22, 2024

The effective ongoing incorporation of Artificial Intelligence (AI) has emerged as a pivotal force within the pharmaceutical sector, reshaping the traditional paradigms of drug discovery, development, and commercialization. However, it’s also charting new waters for consultancies supporting the sector. How do AI and strategy consultants fit together?

Consulting 52

Consulting Training Recruitment Physicians 52

PharmExec

MARCH 22, 2024

In this Pharmaceutical Executive video interview, Optum Rx clinical pharmacist, Arash Sadeghi, discusses the three drugs featured in their Drug Pipeline Insights Report for 2024 and which unmet needs they address.

Pharmaceutical 52

Pharmaceutical 52

PM360

MARCH 22, 2024

Exploring the role of patient advocacy groups and clinical trials while discussing the challenges faced, and how artificial intelligence and modern methods revolutionize the landscape. Despite the unique traits exhibited by approximately 11,000 rare diseases (RD), patients commonly face challenges due to the diseases’ low prevalence, including feelings of isolation and navigating overwhelming information about their condition 1.

Patients 52

Patients Recruitment Ethics Government 52

Advertisement

Distribution

Pharmaceutical Technology

MARCH 22, 2024

Discover how Vanda Pharmaceuticals' patent for R-P88 offers a groundbreaking treatment for psychiatric disorders, simplifying dosing and administration for patients and healthcare providers.

Pharmaceutical 52

Pharmaceutical Healthcare Provider Healthcare Healthcare 52

PM360

MARCH 22, 2024

DISCOVERIES & INNOVATION CAR T Cells May Be the Answer to a Longer Life CAR (chimeric antigen receptor) T cells just might be the secret weapon against aging. Cold Spring Harbor Laboratory (CSHL) Assistant Professor Corina Amor Vegas and colleagues have discovered that T cells are white blood cells that can attack another group known as senescent cells.

Food and Drug Administration 52

Food and Drug Administration FDA Healthcare Healthcare 52

PharmExec

MARCH 22, 2024

Duvyzat (givinostat) is histone deacetylase inhibitor that was previously granted priority review, orphan drug designation, and rare pediatric disease designation by the FDA for patients 6 years of age and older with Duchenne muscular dystrophy.

FDA 52

FDA Patients 52

PM360

MARCH 22, 2024

Clients using eSight, an invention by Gentex, to increase 20/20 vision. Gentex Releases New Technology to Increase 20/20 Vision Gentex, a technology company best known for supplying the automotive, aerospace, and fire protection industries, introduces their new acquisition to help the visually impaired obtain 20/20 vision. This invention is called eSight, and it combines a high-definition camera, proprietary algorithms, and a powerful processing platform to relay and magnify real-time imagery on

Media 52

Media Recruitment Education Medical 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales